why choose us

First received: May 23, 2023

Clinical Trial: Safety and Tolerability of Intravenous Administration of ICVB-1042

Study Status: Completed

Recruit Status: RECRUITING

Condition: Patients With Advanced Solid Tumors

Study Type: INTERVENTIONAL


Official Title: Phase 1 First-in-Human Dose Escalation and Expansion Study to Assess Safety and Tolerability of Intravenous Administration of ICVB-1042 in Patients With Advanced Solid Tumors

Brief Summary: Study to evaluate the safety and tolerability of intravenous ICVB-1042

Read more